Page last updated: 2024-09-02

npc 12626 and eliprodil

npc 12626 has been researched along with eliprodil in 1 studies

Compound Research Comparison

Studies
(npc 12626)
Trials
(npc 12626)
Recent Studies (post-2010)
(npc 12626)
Studies
(eliprodil)
Trials
(eliprodil)
Recent Studies (post-2010) (eliprodil)
5500104323

Protein Interaction Comparison

ProteinTaxonomynpc 12626 (IC50)eliprodil (IC50)
N-methyl-D-aspartate receptor Sus scrofa (pig)0.0826
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)3.3
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)3.3
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.4
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)3.3
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)1.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heikkila, RE; Riordan, DE; Sonsalla, PK1

Other Studies

1 other study(ies) available for npc 12626 and eliprodil

ArticleYear
Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:2

    Topics: Amino Acids; Animals; Corpus Striatum; Dizocilpine Maleate; Male; Methamphetamine; Mice; N-Methylaspartate; Pipecolic Acids; Piperidines; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase

1991